Focus Partners Wealth
EDIT icon

Focus Partners Wealth’s Editas Medicine EDIT Stock Holding History

Focus Partners Wealth’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.3K Buy
27,264
+5,667
+26% +$16.6K ﹤0.01% 2631
2026
Q1 		$53.3K Buy
21,597
+7,739
+56% +$16.4K ﹤0.01% 2576
2025
Q4 		$28.4K Sell
13,858
-5,374
-28% -$15.5K ﹤0.01% 2623
2025
Q3 		$66.9K Sell
19,232
-1,580
-8% -$4.41K ﹤0.01% 2151
2025
Q2 		$45.8K Buy
20,812
+2,062
+11% +$3.37K ﹤0.01% 1981
2025
Q1 		$21.8K Buy
18,750
+6,961
+59% +$10.2K ﹤0.01% 1869
2024
Q4 		$15K Buy
+11,789
New +$30K ﹤0.01% 1858

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Focus Partners Wealth's EDIT Position: Q2 2026 in Review

Focus Partners Wealth increased its Editas Medicine (EDIT) stake by 26% in Q2 2026, buying an estimated $16.6K and bringing the position to 27,264 shares worth $88.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Focus Partners Wealth first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Focus Partners Wealth held 27,264 shares of Editas Medicine worth $88.3K as of Q2 2026.
  • Focus Partners Wealth bought 5,667 Editas Medicine shares in Q2 2026, an estimated $16.6K.
  • Editas Medicine made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2631 holding.
  • Focus Partners Wealth first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.